Funder: IDORSIA PHARMACEUTICALS LTD
edit_calendar Duration: from 24 January 2022 to 23 January 2026 (48 months) Current
euro 6,283.75 EUR

Of International (non-EU) scope. With a Private character.

Call: (IDORSIA PHARMACEUTICALS LTD)

Researchers